ESMO Deep Dive: Breast Cancer – ER+ Metastatic Breast Cancer: Refining Practice and Steering Research 2024

Description

This ESMO Deep Dive Breast Cancer Webinar focused on breakthroughs in personalised, molecularly informed risk prediction, screening and early detection in breast cancer.

This webinar was developed with the aim to provide a second, deeper layer of educational experience in emerging data related to: molecular biology and classification, translational research and biomarkers for precision medicine, and unknowns, hypotheses, and ongoing research in areas of controversy or unmet need for optimal management of patients.

It began with a brief welcome and introduction, then a lecture on how to tackle endocrine resistance, discussing current concepts and ongoing research. This was followed by a talk on breakthrough research on the role of liquid biopsy and molecular analysis, and lastly, by a discussion on the best approach on endocrine refractory patients. The lectures were followed by a live discussion with the speakers’ panel.

This programme was designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with breast cancers, offer expert opinion exchange, and provide some important considerations in this field.